This website is intended for healthcare professionals

Catherine Heffernan explains how nurses can counter the most common myths around vaccination

As of November 2020, there were over 58 million reported cases of COVID-19 disease and almost 1.4 million deaths globally.1 Severe COVID-19 disease disproportionately affects those aged 70 years and older and individuals with comorbidities such as diabetes, chronic respiratory disease and cardiovascular disease.

A safe and effective vaccine against severe COVID-19 disease is needed to help control the global pandemic. In November 2020, 48 potential vaccine candidates were in clinical trials with a further 164 in preclinical testing.2 All vaccines must meet the World Health Organisation product profile for prequalification of a COVID-19 vaccine. This requires vaccines to be targeted at the most at-risk groups; have favourable safety profile; provide efficacy as measured by prevention of virologically confirmed disease or transmission or both; and to provide at least 6 months of protection for individuals at ongoing risk of exposure to the virus (SARS-CoV-2).3

Register now for access

Thank you for visiting Independent Nurse and reading some of our premium content. To read more, please register today. 


Already have an account? Sign in here

Posted under: